Green Fresh Biotechnology Company Limited
1084.HK News Today: Stay Updated with the Latest Green Fresh Biotechnology Company Limited News in Real Time
Find 1084.HK news now at Meyka AI. Stay informed with the latest Green Fresh Biotechnology Company Limited stocks updates, including price news, market analysis, and expert insights.
GAB: Mario Gabelli Acquires 156K Shares on April 28, 2026
Mario Gabelli acquired 156,197 GAB shares at $5.00 on April 28. Director and control person of adviser shows confidence in Gabelli Equity Trust.
MGG.DE Stock Surges 14% on April 30, 2026 – XETRA Intraday Rally
MGG.DE stock jumps 14% to €37.48 on April 30, 2026. MGM Resorts International gains €4.60 in strong intraday trading on XETRA exchange.
5IG.SI Stock Surges 7.8% on High Volume Trading in Singapore
5IG.SI stock jumps 7.8% to S$0.069 with 10M shares traded. Gallant Venture Ltd. shows strong intraday momentum on SES.
CXU.DE Church & Dwight Earnings Preview May 1, 2026
Church & Dwight earnings preview: analysts expect $0.8050 EPS and $1.26B revenue on May 1, 2026. Key metrics and expectations.
AIDX.TO Stock Rises 1.09% in Pre-Market Trading on TSX April 30
AIDX.TO stock gains 1.09% to C$0.93 in pre-market trading. Healwell AI Inc. trades on TSX with 448,600 shares volume.
IHL.AX Stock Drops 10.9% in After-Hours Trading on ASX
IHL.AX stock falls 10.9% to A$0.041 in after-hours trading. Incannex Healthcare faces headwinds despite clinical pipeline progress.
USOPY Stock Holds at $3.95 on PNK Exchange, April 30
USOPY stock trades at $3.95 USD on PNK. U.S. Oil and Gas Plc shows C+ grade with mixed fundamentals and negative earnings.
CPA.DE Colgate-Palmolive Earnings Preview May 1, 2026
Colgate-Palmolive earnings preview: analysts expect $0.8160 EPS and $4.51B revenue on May 1, 2026.
Syngene International Ltd Shares Fall 1.75% to Close at ₹432.30 on BSE
Syngene International Ltd shares slipped 1.75% in the latest trading session on the BSE, closing at ₹432.30 in April 2026. The decline added fresh pressure on the stock after recent volatility in the pharma and biotech space. Investors stayed cautious as earnings outlook and global research demand signals remained mixed. The movement reflects short-term selling…